?
Logo Logo Logo Logo
  • Home
  • About
    • Company Overview
    • History
    • Group Structure
    • ESG
    • Management Team
  • R&D
    • Technology Platform
    • 505(b)(2) NDA
    • High Barrier ANDA
  • Corporate
    • Board of Directors
    • Committee
    • Internal Audit
    • Major Internal Policies
  • Investor
    • Company Profile
    • Financials
    • Shareholders’ Services
    • Stakeholder
  • News
  • Contact
    • Location
    • Join Us
  • Home
  • About
    • Company Overview
    • History
    • Group Structure
    • ESG
    • Management Team
  • R&D
    • Technology Platform
    • 505(b)(2) NDA
    • High Barrier ANDA
  • Corporate
    • Board of Directors
    • Committee
    • Internal Audit
    • Major Internal Policies
  • Investor
    • Company Profile
    • Financials
    • Shareholders’ Services
    • Stakeholder
  • News
  • Contact
    • Location
    • Join Us
Title Image

訊息中心

News

媒體報導

Material Information- Announcement of the Execution Results of the Company’s Treasury Share Buyback

2026-11-06

Material Information- Announcement of the record date for the issuance of restricted employee shares

2026-11-05

Material Information- Announcement of the Board’s Resolution to redeem and cancel restricted employee shares for a capital reduction

2026-11-05

Material Information- Announcement of the Board’s Resolution to release the non-competition restriction on managerial officers

2026-11-05

Material Information- Announcement on behalf of the subsidiary, Handa Pharma, Inc, regarding the change in over one-third of directors

2026-11-05

Material Information- Announcement of the Board of Directors approved the consolidated financial statements for 2026 Q3.

2026-11-05

Material Information- Announces Handa Pharmaceuticals, Inc., and on behalf of the subsidiaries, regarding the 505(b)(2) new formulation drug HND-039 patent infringement lawsuit

2026-11-04

Material Information-The Company was invited to attend the in-person and virtual institutional investor conference hosted by First Securities

2026-11-04

Material Information- The Company was invited to attend the in-person meeting hosted by IBF Securities

2026-09-29

Material Information- The Company was invited to attend the in-person meeting hosted by KGI Securities

2026-09-15
  • 1
  • 2
  • 3
  • …
  • 6
  • ›
Loading...
AboutCompany Overview
History
Group Structure
Photos
Handa US
R&DTechnology Platform
505(b)(2) NDA
High Barrier ANDA
CorporateBoard of Directors
Committee
Internal Audit
Major Internal Policies
InvestorCompany Profile
Financials
Shareholders’ Services
Stakeholder
NewsLatestnews
ContactLocation
Join Us

Copyright © Handa Pharmaceuticals, Inc.